Viewing nowCombinationExvalsa Tablets 10/160mg
Amlodipine Besylate 13.87mg · Valsartan 160mg
Tablet · Prescription medication · Combination
Daewon Biotech Co., Ltd.

MFDS item code 201907959 · Approved 2019.11.18 · Insurance code 057600390
Treatment of essential hypertension not adequately controlled with monotherapy
This medication helps effectively lower blood pressure in patients with essential hypertension for whom control is difficult with either amlodipine or valsartan alone. By combining the mechanisms of action of the two drugs, it assists in the stable management of blood pressure. This contributes to reducing the risk of cardiovascular complications and improving overall health. This medication is used for the treatment of essential hypertension.
The recommended dose of this medicine is 1 tablet once daily, taken with water, regardless of meals. It is recommended that it be taken at the same time each day (e.g., in the morning), if possible. It is recommended that the dose be adjusted using the individual components (amlodipine or valsartan) before administering this medicine. However, if blood pressure is not adequately controlled with monotherapy using the individual components, switching directly to this medicine may be considered as follows. ㆍ5/80 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg monotherapy. ㆍ5/160 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg monotherapy. ㆍ10/160 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg monotherapy, or with 5/160 mg. Patients taking valsartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or higher). However, this medicine should not be administered to patients with severe renal impairment (creatinine clearance below 10mL/min) or patients on dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. Do not administer this medicine to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Patients 65 years of age and older: Use caution when increasing the dose.
Pediatric patients under 18 years of age: Use of this medicine is not recommended, as its safety and efficacy have not been established.
This medication can cause serious harm to the fetus and newborn if taken during the second and third trimesters of pregnancy, so it should be discontinued immediately upon confirmation of pregnancy. People who are allergic to any of the active ingredients or similar drugs, pregnant or breastfeeding women, patients with severe kidney or liver diseases, and those with a history of specific heart diseases or angioedema should not take this medication. Patients who have deficiencies in body sodium or fluids must correct their condition before taking this medication. If symptoms of low blood pressure occur during treatment, the patient should rest immediately by lying down and seek medical help if necessary. Patients with high potassium levels in the blood or those taking other medications that can increase potassium levels should have their potassium levels monitored frequently. Patients with problems in renal blood vessels or those who have recently undergone kidney transplantation may be affected in kidney function when taking this medication, necessitating caution. This medication may cause changes in kidney function in patients with heart failure or after myocardial infarction, so regular kidney function tests are recommended during treatment. Caution is advised during driving or operating machinery, as dizziness or fatigue may occur. Overdosing on this medication may lead to severe hypotension or heart problems, so the dosage must be strictly adhered to, and any unusual symptoms should be reported to healthcare professionals immediately. Additionally, this medication may interact with other specific drugs, so patients should inform their healthcare provider if they are taking other medications. This medication is not recommended for children under the age of 18, and similar doses can be given to elderly patients as to the general adult population. Breastfeeding women should avoid taking this medication, and women who are planning to become pregnant or may become pregnant should not use it.
pharyngitis, influenza, hypersensitivity, visual impairment, anxiety, headache, dizziness, drowsiness, positional dizziness, paresthesia, vertigo, tinnitus, tachycardia, palpitations, syncope, orthostatic hypotension, hypotension, cough, pharyngeal and laryngeal pain, diarrhea, nausea, abdominal pain, constipation, dry mouth, rash, erythema, hyperhidrosis, pruritus, joint swelling, low back pain, arthritis, muscle spasms, lethargy, frequent urination, polyuria, erectile dysfunction, edema, localized edema, facial edema, peripheral edema, fatigue, flushing, weakness, facial flushing, decreased hemoglobin, decreased hematocrit, neutropenia, thrombocytopenia, hypersensitivity including serum sickness, increased serum potassium, vasculitis, elevated liver function tests, angioedema, myalgia, renal failure, kidney damage, elevated serum creatinine, insomnia, decreased libido, pharyngitis, rhinitis, sinusitis, upper respiratory infection, viral infection, diplopia, thrombocytopenia, leukopenia, allergic reaction, hyperglycemia, insomnia, mood changes, tremors, sensory impairment, dysgeusia, peripheral neuropathy, hypertonic muscularity, arrhythmia, bradycardia, atrial fibrillation, ventricular tachycardia, myocardial infarction, vasculitis, dyspnea, rhinitis, vomiting, dyspepsia, pancreatitis, gastritis, gingival hyperplasia, hepatitis, jaundice, alopecia, purpura, skin depigmentation, photosensitivity reaction, angioedema, urticaria, erythema multiforme, Stevens-Johnson syndrome, myalgia, urination disorders, enuresis, gynecomastia, pain, fatigue, chest pain, weight loss, weight gain, elevated liver enzymes, chest discomfort, abdominal discomfort, gastroesophageal reflux, neck pain, hypercholesterolemia, hypoglycemia, nervous irritability, Stevens-Johnson syndrome, arthralgia, skeletal pain, rhabdomyolysis, gingival hyperplasia, gastritis
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent exposure to air or moisture. It is also important to maintain a room temperature between 1 degree and 30 degrees Celsius when storing the medication. This ensures the safety of its effectiveness.
Bright yellow oval film-coated tablet
30 tablets/box [10 tablets/PTP X 3]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationAmlodipine Besylate 13.87mg · Valsartan 160mg
Tablet · Prescription medication · Combination
Daewon Biotech Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
CombinationValsartan 80mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Korea Novartis Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandose Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Myungmoon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.